GS

Garima Singh

Active Director Director DIN 07223090
DIN 07223090 First appointment Apr 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Garima Singh

Data last updated:

Garima Singh is a Director at Affix Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Affix Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (FY 2025).

DIN 07223090
Primary Designation Director
Industry Trading
First Appointment 10 Apr 2023
Oldest Company Age 11 yrs
Largest company Affix Pharmaceuticals Private Limited · ₹4.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20232015₹4.8 Lakh (FY 2025)Active

Board colleagues of Garima Singh

Directorship timeline

Open interactive timeline →
Affix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Garima Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Garima Singh

Garima Singh currently holds 1 directorship: Affix Pharmaceuticals Private Limited (Director, since 10 Apr 2023, revenue ₹4.8 Lakh (FY 2025)).

Garima Singh was first appointed on 10 Apr 2023 as Director at Affix Pharmaceuticals Private Limited.

The current boards of Garima Singh's companies include Poonam Singh (Affix Pharmaceuticals Private Limited), Rajnish Kumar Singh (Affix Pharmaceuticals Private Limited), Ritesh Singh (Affix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available